Mentoring
The 5 types of mentors you need in your life
Everyone can use a mentor. Scratch that — as it turns out, we could all use five mentors. “The best […]
MoreRecent Posts in Pharma, MedTech & Biotech
Roche unlocks new horizons for genomic research in Asia Pacific
November 9, 2026
in News - MedTech & Diagnostics
‘Unexpected and surprising’: Novartis Lp(a) setback raises tough questions for Amgen and Lilly
November 9, 2026
in News - Pharmaceuticals
More public hospitals turn to same-day hip and knee surgery, but key blind spots persist
November 9, 2026
in News - MedTech & Diagnostics
TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning
November 9, 2026
in News - Pharmaceuticals
Stryker partnership helps sustain next generation of humanitarian surgeons
November 9, 2026
in News - MedTech & Diagnostics
National research strategy puts innovation in focus, but commercialisation gaps persist
November 9, 2026
in Medical and Science
WINNERS CROWNED: Health Industry Hub Catalysts for Change Awards 2026
November 6, 2026
in News - MedTech & Diagnostics
Australia’s political duopoly is tone deaf to voters’ changing expectations
November 4, 2026
in News - Pharmaceuticals
Follow Us
Partner with us
News - MedTech & Diagnostics
Roche unlocks new horizons for genomic research in Asia Pacific
Roche is advancing its next-generation sequencing (NGS) ambitions in Asia Pacific following the global launch of AXELIOS 1 in June […]
MoreNews - Pharmaceuticals
‘Unexpected and surprising’: Novartis Lp(a) setback raises tough questions for Amgen and Lilly
The failure of Novartis’ lipoprotein(a) [Lp(a)] therapy to translate substantial biomarker reductions into meaningful cardiovascular benefits has been met with […]
MoreNews - MedTech & Diagnostics
More public hospitals turn to same-day hip and knee surgery, but key blind spots persist
Same-day hip and knee replacements to ease surgical waiting lists are being trialled at The Royal Adelaide Hospital (RAH), but […]
MoreNews - Pharmaceuticals
TGA approves oral Wegovy, prompting questions over efficacy and clinical positioning
The Therapeutic Goods Administration (TGA) approval of Novo Nordisk’s oral GLP-1 receptor agonist Wegovy (semaglutide) is introducing a new dimension to […]
More